TY  - RPRT
TI  - High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting.
AU  - Rushikesh S Joshi
AU  - Amelie Boichard
AU  - Jacob J Adashek
AU  - Razelle Kurzrock
PY  - 2022
DO  - 10.1080/15384047.2022.2128608
UR  - https://pubmed.ncbi.nlm.nih.gov/36171565/
ID  - 36171565
ER  -